Enovix (NASDAQ:ENVX - Get Free Report) was downgraded by Bank of America from a "neutral" rating to an "underperform" rating in a research note issued to investors on Wednesday, FinViz reports. They currently have a $1.00 price target on the stock, down from their previous price target of $5.00. Bank of America's target price would indicate a potential downside of 27.01% from the company's current price.
ENVX has been the subject of a number of other research reports. Cantor Fitzgerald reissued an "overweight" rating and issued a $20.00 target price on shares of Enovix in a research report on Thursday, August 13th. Craig Hallum cut shares of Enovix from a "buy" rating to a "hold" rating and set a $2.00 target price on the stock. in a research note on Friday, November 13th. William Blair downgraded shares of Enovix from an "outperform" rating to a "market perform" rating in a report on Monday, August 17th. TD Cowen upgraded shares of Enovix to a "hold" rating in a research note on Monday, October 5th. Finally, Weiss Ratings reissued a "sell (e+)" rating on shares of Enovix in a report on Friday, October 2nd. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, five have issued a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $6.95.
Check Out Our Latest Research Report on ENVX
Enovix Stock Performance
Shares of ENVX opened at $1.37 on Wednesday. The business's fifty day simple moving average is $2.18 and its two-hundred day simple moving average is $3.88. The company has a current ratio of 9.10, a quick ratio of 9.37 and a debt-to-equity ratio of 3.05. Enovix has a 12 month low of $1.28 and a 12 month high of $9.19. The company has a market cap of $290.73 million, a price-to-earnings ratio of -1.88 and a beta of 2.34.
Enovix (NASDAQ:ENVX - Get Free Report) last posted its earnings results on Friday, November 13th. The company reported ($0.15) EPS for the quarter, topping analysts' consensus estimates of ($0.20) by $0.05. Enovix had a negative return on equity of 73.21% and a negative net margin of 406.54%. The business had revenue of $11.04 million during the quarter. Research analysts anticipate that Enovix will post -0.79 earnings per share for the current fiscal year.
Institutional Trading of Enovix
Large investors have recently modified their holdings of the company. Goldman Sachs Group Inc. grew its position in shares of Enovix by 22.0% during the 3rd quarter. Goldman Sachs Group Inc. now owns 2,038,868 shares of the company's stock valued at $5,913,000 after acquiring an additional 368,066 shares during the period. Cetera Investment Advisers increased its stake in shares of Enovix by 16.2% in the 3rd quarter. Cetera Investment Advisers now owns 207,723 shares of the company's stock worth $602,000 after purchasing an additional 28,965 shares in the last quarter. Jump Financial LLC raised its holdings in Enovix by 185.1% in the 3rd quarter. Jump Financial LLC now owns 1,596,042 shares of the company's stock worth $4,629,000 after purchasing an additional 1,036,189 shares during the period. Caxton Associates LLP bought a new position in Enovix in the 3rd quarter worth $117,000. Finally, First Trust Advisors LP raised its holdings in Enovix by 32.3% in the 3rd quarter. First Trust Advisors LP now owns 774,813 shares of the company's stock worth $2,247,000 after purchasing an additional 188,954 shares during the period. Institutional investors own 50.92% of the company's stock.
About Enovix
(
Get Free Report)
Enovix Corporation develops lithium-ion batteries using a silicon-based anode and a proprietary three-dimensional cell architecture. Its design is intended to increase energy density while addressing safety and performance requirements in compact devices. The company's batteries are designed for applications including smartphones, wearable devices, laptops, augmented- and virtual-reality products, and other portable electronics. Enovix also targets markets such as defense and industrial technology.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Enovix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.
While Enovix currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.